Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,512 | 29 | 91.6% |
| Travel and Lodging | $3,374 | 10 | 7.1% |
| Food and Beverage | $611.73 | 12 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $41,988 | 43 | $0 (2024) |
| AstraZeneca UK Limited | $5,510 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,750 | 2 | AstraZeneca Pharmaceuticals LP ($5,750) |
| 2023 | $1,343 | 1 | AstraZeneca Pharmaceuticals LP ($1,343) |
| 2022 | $7,518 | 5 | AstraZeneca Pharmaceuticals LP ($7,518) |
| 2021 | $2,325 | 2 | AstraZeneca Pharmaceuticals LP ($2,325) |
| 2020 | $6,511 | 4 | AstraZeneca UK Limited ($3,953) |
| 2019 | $2,558 | 3 | AstraZeneca Pharmaceuticals LP ($2,558) |
| 2018 | $12,541 | 15 | AstraZeneca Pharmaceuticals LP ($12,541) |
| 2017 | $8,953 | 19 | AstraZeneca Pharmaceuticals LP ($7,396) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Respiratory | ||||||
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $1,342.50 | General |
| Category: Respiratory | ||||||
| 10/10/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Respiratory | ||||||
| 08/16/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| Category: Respiratory | ||||||
| 07/27/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $1,342.50 | General |
| Category: Respiratory | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| Category: Respiratory | ||||||
| 04/24/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $805.50 | General |
| Category: Respiratory | ||||||
| 11/02/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: Respiratory | ||||||
| 03/11/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: Respiratory | ||||||
| 12/03/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: Respiratory | ||||||
| 10/14/2020 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,952.50 | General |
| 09/24/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,395.00 | General |
| Category: Respiratory | ||||||
| 06/22/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $698.00 | General |
| Category: Respiratory | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| Category: Respiratory | ||||||
| 04/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $698.00 | General |
| Category: Respiratory | ||||||
| 02/25/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| Category: Respiratory | ||||||
| 12/17/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $5,580.00 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $511.58 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $219.94 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $216.56 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 09/13/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 39 | $13,065 | $2,321 |
| 2021 | 1 | 16 | 35 | $16,100 | $2,749 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 39 | $13,065 | $2,321 | 17.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 35 | $16,100 | $2,749 | 17.1% |
About Dr. Siddhartha Singh, MD
Dr. Siddhartha Singh, MD is a Hospitalist healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437101169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Siddhartha Singh, MD has received a total of $47,498 in payments from pharmaceutical and medical device companies, with $5,750 received in 2024. These payments were reported across 51 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($43,512).
As a Medicare-enrolled provider, Singh has provided services to 28 Medicare beneficiaries, totaling 74 services with total Medicare billing of $5,070. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Milwaukee, WI
- Active Since 05/17/2006
- Last Updated 10/14/2014
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1437101169
Products in Payments
- FASENRA (Drug) $17,657
- FASENRA (Biological) $13,186
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Milwaukee
Harsimran Sekhon
Hospitalist — Payments: $8,947
Arun Kumar, Md, MD
Hospitalist — Payments: $1,139
Dr. Raymundo Garcia-Dwyer, M.d, M.D
Hospitalist — Payments: $1,108
Ahmed Khan, M.d, M.D
Hospitalist — Payments: $891.92
Dr. Usonwanne Ibekwe, M.d, M.D
Hospitalist — Payments: $692.89
Jeffrey Stein
Hospitalist — Payments: $630.19